DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Vision - Eradicate deaths from lung cancer to better the health and welfare of the military and the American public

Lung Cancer Research Program Cover Image

» Click on Image to View Program Booklet

Lung cancer is the leading cause of cancer-related deaths in the United States, and claims more lives each year than all other major cancers combined. This year, more than 221,200 U.S. men and women will be diagnosed with lung cancer, and over 158,040 will die from the disease. Lung cancers are generally diagnosed at an advanced, incurable stage because patients often lack signs and symptoms in the early stages of the disease. Several factors have been shown to contribute to the development of lung cancer, smoking and exposure to environmental carcinogens being the most prevalent, but many people who do not smoke also develop lung cancer each year. Importantly, military personnel are at a higher risk of developing lung cancer than the general population due to increased rates of smoking as well as an increased likelihood of being exposed to environmental carcinogens during their service.




Congressional Appropriations

Congressional Appropriations

  • $79.0 million
    FY09-FY14
  • $10.5 million
    FY15

Funding Summary

Funding
Summary


Dr. Avrum Spira

Boston University Medical Campus
Detection of Early Lung Cancer Among Military Personnel (DECAMP)

news_icon News & Highlights

Vision

Eradicate deaths from lung cancer to better the health and welfare of the military and the American public

Mission

Support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer

Last updated Friday February 05 2016